ישראל - עברית - Ministry of Health

taro international ltd, israel - capecitabine - טבליות מצופות פילם - capecitabine 500 mg - capecitabine

ישראל - עברית - Ministry of Health

becton dickinson (bd) israel ltd., israel - chlorhexidine gluconate; isopropyl alcohol - isopropyl alcohol 0.7 ml / 1 ml; chlorhexidine gluconate 20 mg / 1 ml - chlorhexidine, combinations

ישראל - עברית - Ministry of Health

becton dickinson (bd) israel ltd., israel - chlorhexidine gluconate; isopropyl alcohol - isopropyl alcohol 0.7 ml/ml; chlorhexidine gluconate 20 mg/ml - chlorhexidine, combinations

ישראל - עברית - Ministry of Health

ferring pharmaceuticals ltd - progesterone - טבליות וגינליות - progesterone 100 mg - progesterone - progesterone - progesterone supplementation or replacement in cases such as treatment of infertile women and ivf.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - medroxyprogesterone acetate - טבליה - medroxyprogesterone acetate 5 mg - medroxyprogesterone - medroxyprogesterone - in cases requiring progesterone supplement.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - medroxyprogesterone acetate - תרחיף להזרקה - medroxyprogesterone acetate 104 mg / 0.65 ml - medroxyprogesterone - medroxyprogesterone - * sayana is indicated for long-term female contraception. each subcutaneous injection prevents ovulation and provides contraception for at least 13 weeks (+/- 1 week). however, it should be taken into consideration that the return to fertility (ovulation) may be delayed for up to one year .since loss of bone mineral density may occur in females of all ages who use sayana long-term, a risk/benefit assessment, which also takes into consideration the decrease in bone mineral density that occurs during pregnancy and/or lactation, should be considered.* use in adolescents (12-18 years)in adolescents, use of sayana is only indicated when other contraceptive methods are considered unsuitable or unacceptable, due to unknown long-term effects of bone loss associated with sayana during the critical period of bone accretion.sayana has not been studied in women under the age of 18 years but data is available for intramuscular medroxyprogesterone acetate in this population.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - medroxyprogesterone acetate - תרחיף להזרקה - medroxyprogesterone acetate 150 mg/ml - medroxyprogesterone - medroxyprogesterone - for contraception where medically indicated and oral administration is inapplicable.

ישראל - עברית - Ministry of Health

ferring pharmaceuticals ltd - progesterone - תמיסה להזרקה - progesterone 50 mg/ml - progesterone - progesterone - disfunctional uterine bleeding and in selected cases as an addition to treatment of infertility with techniques such as ivf, gift.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - medroxyprogesterone acetate - תרחיף להזרקה - medroxyprogesterone acetate 150 mg/ml - medroxyprogesterone - medroxyprogesterone - palliation of inoperable recurrent or metastatic carcinoma of endometrium, breast, ovary and kidney.

ישראל - עברית - Ministry of Health

cts ltd - progesterone micronized - קפסולות - progesterone micronized 200 mg - progesterone - progesterone - vaginal administration: progesterone substitution for ovary deprived women in situation of total progesterone deficiency. supplementation of the luteal phase during in vitro fertilization cycles. supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. in cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. for all other progesterone indication, in the case of : adverse events due to progesterone, contraindication of the oral route of administration hepatopathy. vaginal or oral addministration: disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).